Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

ELTGOL airway clearance in bronchiectasis: laying the bricks of evidence

Conroy Wong, Cameron Sullivan, Lata Jayaram
European Respiratory Journal 2018 51: 1702232; DOI: 10.1183/13993003.02232-2017
Conroy Wong
1Counties Manukau District Health Board, Dept of Respiratory Medicine, Middlemore Hospital, Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: conroy.wong@middlemore.co.nz
Cameron Sullivan
1Counties Manukau District Health Board, Dept of Respiratory Medicine, Middlemore Hospital, Auckland, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lata Jayaram
2The University of Melbourne, Dept of Medicine, Melbourne Clinical School, Melbourne, Australia
3Dept of Respiratory and Sleep Medicine, Western Health, St Albans, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

ELTGOL therapy is one of the best evidence-based airway clearance techniques for bronchiectasis http://ow.ly/vXmU30gZUSR

The thought that flickers almost as a reflex when we think about airway clearance techniques in bronchiectasis is “where is the evidence?” A solid foundation for the efficacy of treatments should be based on randomised controlled trials. Currently, the evidence base is sparse but fortunately the field has not been abandoned.

Current international guidelines recommend airway clearance techniques as part of routine management of patients with bronchiectasis [1–3]. Since impaired mucociliary clearance and sputum retention are core elements in the pathophysiology of bronchiectasis [4, 5], the rationale for use of nonpharmacological interventions that facilitate removal of sputum appears reasonable. A wide variety of airway clearance techniques are available. These include postural drainage, manual techniques (percussion or clapping), breathing strategies (active cycle of breathing or autogenic drainage), positive expiratory pressure (PEP) devices and airway oscillating devices [6]. Recent Cochrane reviews evaluating the effects of these techniques have found the quality of the evidence to be low: few randomised controlled trials have been undertaken and the longest duration of intervention was 3 months [7, 8].

A less well known but increasingly popular technique for airway clearance is slow expiration with the glottis opened in a lateral posture or ELTGOL (L'Expiration Lente Totale Glotte Ouverte en décubitus Latéral), which was first described by Postiaux et al. [9] in 1987. In this technique, the patient lies in a lateral decubitus position and breathes out slowly through an open glottis from functional residual capacity to residual volume. The goal is to control expiratory flow to prevent airway closure and facilitate mucus clearance. In contrast to conventional postural drainage, mucus clearance is only increased in the dependent, inferiorly positioned lung [10].

Mucus is cleared from the respiratory tract by two main mechanisms: ciliary transport and expiratory airflow [11]. Many airway clearance techniques, including ELTGOL, are based on increasing airflow clearance by a mechanism known as two-phase gas–liquid flow [12]. In this model, when air flows over mucus it creates a shear force that can overcome the resistive forces in the mucus layer. The higher the velocity of airflow the greater the shear force is. In the ELTGOL technique, the volume of the dependent lung is reduced by placing the patient in the lateral decubitus position and by limiting breathing to expiratory reserve volume [13]. This reduces total cross-sectional area of the peripheral airways where mucus is primarily produced. Since maximum airflow velocity is inversely proportional to airway diameter, the velocity of airflow in the peripheral airways is increased [14]. Airway patency is maintained by increasing intraluminal pressure via slow expiration through an open glottis [15]. Overall, this results in greater clearance of mucus from the peripheral airways [10].

In this issue of the European Respiratory Journal, Muñoz et al. [16] report results from their randomised, placebo-controlled, 12-month trial, in which they assessed the effects of twice-daily ELTGOL treatment for airway clearance in patients with bronchiectasis and chronic sputum production. ELTGOL airway clearance significantly increased overall 24-h sputum volume (during first intervention and 24 h later) by 17 mL compared to placebo. The ELTGOL technique also increased sputum clearance, reduced symptom-based exacerbations and improved health-related quality of life after 12 months. No effects on lung function, exercise capacity, dyspnoea or inflammatory markers were noted.

It is often assumed that chest physiotherapy increases sputum clearance. However, the study by Muñoz et al. [16] is one of only two placebo-controlled studies of airways clearance techniques that have evaluated sputum volume as the primary outcome. A previous crossover study with nine participants compared oscillating PEP therapy using a flutter device with sham treatment using a flutter device without a sphere [17]. However, it is possible that the sham procedure, which involved breathing from full inspiratory capacity, could have affected the primary outcome [7]. Studies of physiotherapy interventions are notoriously difficult to blind and in the study by Muñoz et al. [16], the sham procedure used was upper-limb stretching exercises. At first glance it is obvious that the placebo control intervention is not similar to the active treatment. However, use of such a control intervention in order to avoid affecting the primary outcome may be justified if patients are adequately blinded to the treatment hypothesis [18].

The distinguishing feature of the study by Muñoz et al. [16] relative to other clinical trials is the longer duration of intervention and analysis of clinically relevant endpoints after 12 months. The health-related quality of life questionnaires, St George's Respiratory Questionnaire (SGRQ) and Leicester Cough Questionnaire (LCQ), are well established outcomes for clinical trials in bronchiectasis [19, 20]. Clinically important improvements in the SGRQ and LCQ scores were recorded in the ELTGOL group compared to the placebo group. These longer-term findings provide support for sputum volume as a clinically relevant endpoint. Fewer exacerbations were also seen in the ELTGOL group. However, caution should be taken when interpreting exacerbations in this study because a symptom-based definition has not been established as a responsive outcome measure in bronchiectasis studies. A more convincing but as yet untested consensus definition of an exacerbation based on symptoms and a change in treatment has recently been published in the European Respiratory Journal [21].

Should we now prescribe the ELTGOL intervention as the preferred airway clearance option for our patients with bronchiectasis? Arguably, it now has the strongest evidence base, albeit still limited, of all the available airways clearance techniques. Previous studies have established the physiological and biomechanical basis for treatment [10, 13]. It is simple, inexpensive, well tolerated, able to be performed independently or with the aid of a physiotherapist [13], a reproducible technique [13], and supported by randomised clinical trials [8, 16, 22, 23]. A recent randomised trial also showed that ELTGOL therapy compared favourably to two other slow expiratory airway clearance techniques (autogenic drainage and temporary PEP) [23].

When choosing from the myriad of airway clearance techniques available, it is worth contemplating for more than a moment the thought that ELTGOL therapy is one of the best evidence-based options. The foundation bricks for this technique are now well embedded but clearly further research and larger studies are required to build on the evidence, particularly for long-term patient-centred outcomes. Consideration could also be given to combining ELTGOL therapy with other evidence-based treatment modalities such as pulmonary rehabilitation and exercise training [3, 24].

Footnotes

  • Conflict of interest: None declared.

  • Received October 30, 2017.
  • Accepted October 31, 2017.
  • Copyright ©ERS 2018

References

  1. ↵
    1. Pasteur MC,
    2. Bilton D,
    3. Hill AT
    , et al. British Thoracic Society guideline for non-CF bronchiectasis. Thorax 2010; 65: Suppl. 1, i1–i58.
    OpenUrlAbstract/FREE Full Text
    1. Chang AB,
    2. Bell SC,
    3. Torzillo PJ
    , et al. Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines. Med J Aust 2015; 202: 130.
    OpenUrl
  2. ↵
    1. Polverino E,
    2. Goeminne PC,
    3. McDonnell MJ
    , et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J 2017; 50: 1700629.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Currie DC,
    2. Pavia D,
    3. Agnew JE
    , et al. Impaired tracheobronchial clearance in bronchiectasis. Thorax 1987; 42: 126–130.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. McShane PJ,
    2. Naureckas ET,
    3. Tino G
    , et al. Non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2013; 188: 647–656.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Flude LJ,
    2. Agent P,
    3. Bilton D
    . Chest physiotherapy techniques in bronchiectasis. Clin Chest Med 2012; 33: 351–361.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Lee AL,
    2. Burge AT,
    3. Holland AE
    . Airway clearance techniques for bronchiectasis. Cochrane Database Syst Rev 2015; CD008351.
  7. ↵
    1. Lee AL,
    2. Burge AT,
    3. Holland AE
    . Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis. Cochrane Database Syst Rev 2017; CD011699.
  8. ↵
    1. Postiaux G,
    2. Lens E,
    3. Alsteens G
    . L'Expiration Lente Totale Glotte Ouverte en décubitus Latéral (ELTGOL): nouvelle manoeuvre pour la toilette bronchique objectivée par vidéobronchographie. Ann Kinésithér 1987; 14: 341–350.
    OpenUrl
  9. ↵
    1. Martins JA,
    2. Dornelas de Andrade A,
    3. Britto RR
    , et al. Effect of slow expiration with glottis opened in lateral posture (ELTGOL) on mucus clearance in stable patients with chronic bronchitis. Respir Care 2012; 57: 420–426.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Button BM,
    2. Button B
    . Structure and function of the mucus clearance system of the lung. Cold Spring Harb Perspect Med 2013; 3: a009720.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Kim CS,
    2. Iglesias AJ,
    3. Sackner MA
    . Mucus clearance by two-phase gas–liquid flow mechanism: asymmetric periodic flow model. J Appl Physiol (1985) 1987; 62: 959–971.
    OpenUrlPubMedWeb of Science
  12. ↵
    1. Lanza FC,
    2. Alves CS,
    3. dos Santos RL
    , et al. Expiratory reserve volume during slow expiration with glottis opened in infralateral decubitus position (ELTGOL) in chronic pulmonary disease: technique description and reproducibility. Respir Care 2015; 60: 406–411.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Van der Schans CP
    . Bronchial mucus transport. Respir Care 2007; 52: 1150–1156.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Voets PJ,
    2. van Helvoort HA
    . The role of equal pressure points in understanding pulmonary diseases. Adv Physiol Educ 2013; 37: 266–267.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Muñoz G,
    2. de Gracia J,
    3. Buxó M
    , et al. Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial. Eur Respir J 2017; 51: 1701926.
    OpenUrl
  16. ↵
    1. Figueiredo PH,
    2. Zin WA,
    3. Guimaraes FS
    . Flutter valve improves respiratory mechanics and sputum production in patients with bronchiectasis. Physiother Res Int 2012; 17: 12–20.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Boutron I,
    2. Guittet L,
    3. Estellat C
    , et al. Reporting methods of blinding in randomized trials assessing nonpharmacological treatments. PLoS Med 2007; 4: e61.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Wilson CB,
    2. Jones PW,
    3. O'Leary CJ
    , et al. Validation of the St. George's Respiratory Questionnaire in bronchiectasis. Am J Respir Crit Care Med 1997; 156: 536–541.
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    1. Murray MP,
    2. Turnbull K,
    3. MacQuarrie S
    , et al. Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis. Eur Respir J 2009; 34: 125–131.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    1. Hill AT,
    2. Haworth CS,
    3. Aliberti S
    , et al. Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research. Eur Respir J 2017; 49: 1700051.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Guimaraes FS,
    2. Moco VJ,
    3. Menezes SL
    , et al. Effects of ELTGOL and Flutter VRP1® on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Rev Bras Fisioter 2012; 16: 108–113.
    OpenUrlPubMed
  22. ↵
    1. Herrero-Cortina B,
    2. Vilaro J,
    3. Marti D
    , et al. Short-term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy 2016; 102: 357–364.
    OpenUrl
  23. ↵
    1. Lee AL,
    2. Hill CJ,
    3. McDonald CF
    , et al. Pulmonary rehabilitation in individuals with non-cystic fibrosis bronchiectasis: a systematic review. Arch Phys Med Rehabil 2017; 98: 774–82.
    OpenUrl
PreviousNext
Back to top
View this article with LENS
Vol 51 Issue 1 Table of Contents
European Respiratory Journal: 51 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
ELTGOL airway clearance in bronchiectasis: laying the bricks of evidence
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
ELTGOL airway clearance in bronchiectasis: laying the bricks of evidence
Conroy Wong, Cameron Sullivan, Lata Jayaram
European Respiratory Journal Jan 2018, 51 (1) 1702232; DOI: 10.1183/13993003.02232-2017

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
ELTGOL airway clearance in bronchiectasis: laying the bricks of evidence
Conroy Wong, Cameron Sullivan, Lata Jayaram
European Respiratory Journal Jan 2018, 51 (1) 1702232; DOI: 10.1183/13993003.02232-2017
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Footnotes
    • References
  • Info & Metrics
  • PDF

Subjects

  • CF and non-CF bronchiectasis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • All roads lead to COPD… or not?
  • Insights in the biology of IL-33 and relevance for COPD
  • Sotatercept, haemodynamics and the right ventricle
Show more Editorials

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society